Tag: #Global Trends

The U.S. Food and Drug Administration (FDA) has officially approved Exdensur (depemokimab), an add-on biologic maintenance treatment for severe asthma... Read more

Galux, a South Korean biotech firm pioneering AI-driven protein therapeutics discovery, has formally entered into a research agreement with Boehringer... Read more

Gilead Sciences Inc. has officially announced the appointment of Keeley Wettan as Executive Vice President, General Counsel, Legal & Compliance.... Read more

Life science leaders Chitose Laboratory Corp. and Fujifilm Biosciences Inc. have officially formed a strategic alliance. This partnership aims to... Read more

The U.S. Food and Drug Administration (FDA) has officially granted approval for Rybrevant Faspro, a therapy targeting epidermal growth factor... Read more

Nxera Pharma (formerly Sosei Group) is actively seeking buyers or strategic partners for its schizophrenia drug program after Boehringer Ingelheim... Read more

Pharmaceutical giant Eli Lilly has released Phase III (ATTAIN-MAINTAIN) data for orforglipron, an oral GLP-1 receptor agonist. The drug is... Read more

In a landmark move, nine multinational pharmaceutical companies have signed agreements with the White House to lower prices for various... Read more

Researchers at Binghamton University (USA) have announced a breakthrough approach in developing cancer treatment vaccines. By combining mRNA technology with... Read more